Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.

Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF; Diabetes Prevention Program Research Group.

Diabet Med. 2014 Sep;31(9):1064-8. doi: 10.1111/dme.12437. Epub 2014 Apr 9.

2.

Interaction between dietary fat and exercise on excess postexercise oxygen consumption.

Frost EA, Redman LM, de Jonge L, Rood J, Zachwieja JJ, Volaufova J, Bray GA, Smith SR.

Am J Physiol Endocrinol Metab. 2014 May 1;306(9):E1093-8. doi: 10.1152/ajpendo.00383.2013. Epub 2014 Mar 18.

3.

Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.

Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ; Diabetes Prevention Program Research Group.

Diabetologia. 2014 May;57(5):935-9. doi: 10.1007/s00125-014-3183-2. Epub 2014 Feb 20.

4.

Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence.

Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL; Diabetes Prevention Program Research Group.

Int J Behav Nutr Phys Act. 2014 Feb 12;11:16. doi: 10.1186/1479-5868-11-16.

5.

Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.

Franks PW, Christophi CA, Jablonski KA, Billings LK, Delahanty LM, Horton ES, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2014 Mar;57(3):485-90. doi: 10.1007/s00125-013-3133-4. Epub 2013 Dec 7.

6.

Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.

Christophi CA, Resnick HE, Ratner RE, Temprosa M, Fowler S, Knowler WC, Shamoon H, Barrett-Connor E, Kahn SE; Diabetes Prevention Program Research Group.

J Diabetes Complications. 2013 Mar-Apr;27(2):150-7. doi: 10.1016/j.jdiacomp.2012.09.012. Epub 2012 Nov 7.

7.

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC; Diabetes Prevention Program Research Group.

PLoS One. 2012;7(9):e44424. doi: 10.1371/journal.pone.0044424. Epub 2012 Sep 11.

8.

Curvilinear dose-response relationship of carbohydrate (0-120 g·h(-1)) and performance.

Smith JW, Pascoe DD, Passe DH, Ruby BC, Stewart LK, Baker LB, Zachwieja JJ.

Med Sci Sports Exerc. 2013 Feb;45(2):336-41. doi: 10.1249/MSS.0b013e31827205d1.

PMID:
22968309
9.

Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.

Pollin TI, Isakova T, Jablonski KA, de Bakker PI, Taylor A, McAteer J, Pan Q, Horton ES, Delahanty LM, Altshuler D, Shuldiner AR, Goldberg RB, Florez JC, Franks PW; Diabetes Prevention Program Research Group.

PLoS Genet. 2012;8(8):e1002895. Epub 2012 Aug 30.

10.

The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program.

Florez JC, Jablonski KA, Taylor A, Mather K, Horton E, White NH, Barrett-Connor E, Knowler WC, Shuldiner AR, Pollin TI; Diabetes Prevention Program Research Group.

Diabetes Care. 2012 Sep;35(9):1864-7. Epub 2012 Jun 29.

11.

Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.

Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW; Diabetes Prevention Program Research Group.

Diabetes Care. 2012 Feb;35(2):363-6. doi: 10.2337/dc11-1328. Epub 2011 Dec 16.

12.

TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program.

McCaffery JM, Jablonski KA, Franks PW, Dagogo-Jack S, Wing RR, Knowler WC, Delahanty L, Dabelea D, Hamman R, Shuldiner AR, Florez JC; Diabetes Prevention Program Research Group.

PLoS One. 2011;6(7):e21518. doi: 10.1371/journal.pone.0021518. Epub 2011 Jul 26.

13.

Menopause and risk of diabetes in the Diabetes Prevention Program.

Kim C, Edelstein SL, Crandall JP, Dabelea D, Kitabchi AE, Hamman RF, Montez MG, Perreault L, Foulkes MA, Barrett-Connor E; Diabetes Prevention Program Research Group.

Menopause. 2011 Aug;18(8):857-68. doi: 10.1097/gme.0b013e31820f62d0.

14.

Fuel selection and cycling endurance performance with ingestion of [13C]glucose: evidence for a carbohydrate dose response.

Smith JW, Zachwieja JJ, Péronnet F, Passe DH, Massicotte D, Lavoie C, Pascoe DD.

J Appl Physiol (1985). 2010 Jun;108(6):1520-9. doi: 10.1152/japplphysiol.91394.2008. Epub 2010 Mar 18.

15.

Serum sodium concentration changes are related to fluid balance and sweat sodium loss.

Pahnke MD, Trinity JD, Zachwieja JJ, Stofan JR, Hiller WD, Coyle EF.

Med Sci Sports Exerc. 2010 Sep;42(9):1669-74. doi: 10.1249/MSS.0b013e3181d6c72a.

PMID:
20142773
16.

First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes.

Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SL, Hamman RF, Hoskin MA, Knowler WC, Ma Y; Diabetes Prevention Program Research Group.

Int J Obes (Lond). 2008 Oct;32(10):1537-44. doi: 10.1038/ijo.2008.134. Epub 2008 Aug 19. Erratum in: Int J Obes (Lond). 2009 Jan;33(1):182.

17.

Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.

Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, Franks PW, Hanson RL, Shuldiner AR, Knowler WC, Altshuler D, Florez JC; Diabetes Prevention Program Research Group.

Diabetes. 2008 Sep;57(9):2503-10. doi: 10.2337/db08-0284. Epub 2008 Jun 10.

18.

Carbohydrate and carbohydrate + protein for cycling time-trial performance.

Osterberg KL, Zachwieja JJ, Smith JW.

J Sports Sci. 2008 Feb 1;26(3):227-33.

PMID:
18074296
19.

Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.

Pasarica M, Zachwieja JJ, Dejonge L, Redman S, Smith SR.

J Clin Endocrinol Metab. 2007 Nov;92(11):4265-70. Epub 2007 Sep 4.

PMID:
17785361
20.

Sweat and sodium losses in NCAA football players: a precursor to heat cramps?

Stofan JR, Zachwieja JJ, Horswill CA, Murray R, Anderson SA, Eichner ER.

Int J Sport Nutr Exerc Metab. 2005 Dec;15(6):641-52.

PMID:
16521848

Supplemental Content

Loading ...
Support Center